BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9213647)

  • 1. [Aprotinin in orthotopic liver transplantation].
    García Huete L; Sabaté Pes A
    Med Clin (Barc); 1997 Mar; 108(11):439. PubMed ID: 9213647
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aprotinin in the control of surgical hemorrhage].
    Rocha E; Antonio Páramo J; Hermida J
    Med Clin (Barc); 1996 Mar; 106(8):307-16. PubMed ID: 8667690
    [No Abstract]   [Full Text] [Related]  

  • 3. [Liver transplantation: the problem of peroperative bleeding].
    Roseau E
    Presse Med; 2000 Jul; 29(23):1289-90. PubMed ID: 10923137
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood product use during orthotopic liver transplantation.
    Shan WL; Barkun J; Metrakos P; Tchervenkov J; Backman SB
    Can J Anaesth; 2004 Dec; 51(10):1045-6. PubMed ID: 15574559
    [No Abstract]   [Full Text] [Related]  

  • 5. Does aprotinin really reduce blood loss in orthotopic liver transplantation?
    Groh J; Welte M; Azad SC; Anthuber M; Haller M; Kratzer MA
    Semin Thromb Hemost; 1993; 19(3):306-8. PubMed ID: 7689758
    [No Abstract]   [Full Text] [Related]  

  • 6. Pro: Antifibrinolytics are safe and effective in patients undergoing liver transplantation.
    Lerner AB
    J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):888-90. PubMed ID: 17138101
    [No Abstract]   [Full Text] [Related]  

  • 7. Con: Antifibrinolytics are not safe and effective in patients undergoing liver transplantation.
    Ramsay MA
    J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):891-3. PubMed ID: 17138102
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of high-dose aprotinin on hemostasis and blood requirement in orthotopic liver transplantation.
    Grosse H; Lobbes W; Frambach M; Ringe B; Barthels M
    Semin Thromb Hemost; 1993; 19(3):302-5. PubMed ID: 7689757
    [No Abstract]   [Full Text] [Related]  

  • 9. Aprotinin and nafamostat mesilate in liver surgery: effect on blood loss.
    Pereboom IT; de Boer MT; Porte RJ; Molenaar IQ
    Dig Surg; 2007; 24(4):282-7. PubMed ID: 17657153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aprotinin during liver transplantation.
    Lentschener C; Benhamou D
    Br J Anaesth; 1996 Jun; 76(6):882. PubMed ID: 8679372
    [No Abstract]   [Full Text] [Related]  

  • 11. Aprotinin in orthotopic liver transplantation.
    Bechstein WO; Riess H; Blumhardt G; Himmelreich G; Jochum M; Gerlach H; Rossaint R; Keck H; Neuhaus P
    Semin Thromb Hemost; 1993; 19(3):262-7. PubMed ID: 7689751
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effects of aprotinin. Blood loss and coagulation parameters in orthotopic liver transplantation: A clinical-experimental, prospective and randomized double-blind study].
    Kratzer MA; Azad SC; Groh J; Welte M; Haller M; Pratschke E
    Anaesthesist; 1997 Apr; 46(4):294-302. PubMed ID: 9229983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of aprotinin in Norway.
    Bjella L; Greiff G; Pleym H; Stenseth R; Wahba A
    Acta Anaesthesiol Scand; 2007 Feb; 51(2):261; author reply 261. PubMed ID: 17261150
    [No Abstract]   [Full Text] [Related]  

  • 14. Aprotinin: safe and effective in all patients undergoing orthotopic liver transplantation?
    Porte RJ; Slooff MJ
    Liver Transpl; 2001 Sep; 7(9):808-10. PubMed ID: 11552216
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
    Ickx BE; van der Linden PJ; Melot C; Wijns W; de Pauw L; Vandestadt J; Hut F; Pradier O
    Transfusion; 2006 Apr; 46(4):595-605. PubMed ID: 16584436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is aprotinin safe when used in the context of profound hypothermia and circulatory arrest? A literary review.
    Hornick P; Taylor KM
    J Heart Valve Dis; 1995 Nov; 4(6):669-73. PubMed ID: 8611984
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction of blood loss using high-dose aprotinin in major orthopaedic surgery.
    Slappendel R; Dirksen R; Van Hellemondt GG
    J Bone Joint Surg Br; 2004 May; 86(4):620; author reply 620-1. PubMed ID: 15174566
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aprotinine: safe use in surgical practice].
    Dement'eva II; Charnaia MA; Morozov IuA
    Anesteziol Reanimatol; 2007; (2):69-71. PubMed ID: 17564008
    [No Abstract]   [Full Text] [Related]  

  • 19. Aprotinin and cardiac surgery.
    DeAnda A
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):492-4. PubMed ID: 18329458
    [No Abstract]   [Full Text] [Related]  

  • 20. [Aprotinin in cardiac surgery: one paper of the year or a provocation from the New England Journal of Medicine].
    Blanloeil Y
    Ann Fr Anesth Reanim; 2006 Jul; 25(7):683-5. PubMed ID: 16919751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.